Tarek Alasil, MD | UniHealth

Offices

1 location · Retina Institute of California Medical Group, A California Medical Par · 76 clinicians in this group

Looking this up.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Alasil’s office at (760) 779-0800 to ask if they take your plan before you enroll.

California Medical Board record

Licence A108797 · Current

Licensed to practise in California · since 2009 · expires 2027-04-30 · University of Aleppo Faculty of Medicine. Board flags: Public Reprimand, Admin Action By Other State/Fed Gov'T.

Public record actions

Sort by

Actions the Medical Board of California publishes for this licence

2017-01-13	Board disciplineDiscipline	Public reprimand. · 8002015018010

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

American Board of Ophthalmology - Ophthalmology

Original Medicare doctor bills

$660,380

Medicare paid this office $660,380 for 259 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Injection, faricimab-svoa, 0.1 mg	38	$332,850	None
Established patient complete exam of visual system	231	$79,843	$100
Injection of drug into eye	71	$43,396	$93
Injection, ranibizumab, 0.1 mg	14	$38,636	None
Imaging of retina	256	$37,539	$32

See all 10 services

Sort by

Every Original Medicare service billed

Injection, faricimab-svoa, 0.1 mg	38	$332,850	None
Established patient complete exam of visual system	231	$79,843	$100
Injection of drug into eye	71	$43,396	$93
Injection, ranibizumab, 0.1 mg	14	$38,636	None
Imaging of retina	256	$37,539	$32
Destruction of leaking blood vessels of retina using laser	23	$10,343	$287
Exam of retinal blood vessels using a special camera after injection of a dye	52	$7,800	$132
Compounded drug, not otherwise classified	35	$7,035	None
New patient visit (45+ min)	32	$3,712	$116
Established patient problem focused exam of visual system	16	$2,123	$76

Procedures Medicare counted

Sort by

Procedure volume Medicare published

Cataract surgery	26	More than 50% of doctors who do this

Procedures year by year

Procedures billed to Original Medicare by year
Procedure	2019	2020	2021	2022	2023	2024
Injection of drug into eye	409	441	446	650	572	467
Destruction of leaking blood vessels of retina using laser	53	53	43	55	43	36
Destruction of growth of retina using a laser	16	–	–	–	–	–
Photocoagulation treatment to prevent detachment of retina	12	–	–	–	–	–

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

259 Original Medicare patients in 2024. Average age 70 · Under 65 17% · 85 and older 10% · Women 49% · Also on Medicaid 78% · Health risk score 2.61. Sicker patients than 9 in 10 peers; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 75% · Diabetes 67% · Chronic kidney disease 37% · Coronary heart disease 29% · Heart failure 27% · Depression 16% · COPD 15% · Atrial fibrillation 13% · Stroke 13% · Cancer 10% · Dementia 9%.

The office billed $2,102,439, Medicare allowed $850,460 and paid $660,380; for 15,398 services of 44 kinds; $438,311 of it was for drugs given in the office and $222,069 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	259	15,398	70	2.61	$2,102,439	$660,380
2023	226	8,046	70	2.19	$1,922,495	$632,759
2022	195	5,224	71	1.94	$2,182,190	$772,039
2021	211	3,880	70	2.02	$1,586,383	$591,633
2020	197	3,805	71	2.16	$1,811,983	$595,499
2019	207	3,647	72	2.32	$1,756,016	$578,627
2018	145	1,339	74	2.65	$430,283	$134,613
2017	42	196	69	3.04	$51,251	$17,321
2014	155	504	76	2.52	$111,454	$45,498
2013	541	1,540	73	2.01	$383,173	$150,963

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 13 services

Sort by

Original Medicare services billed in 2023

Injection, ranibizumab, 0.1 mg	41	$196,727	None
Injection, faricimab-svoa, 0.1 mg	20	$108,837	None
Established patient complete exam of visual system	198	$91,424	$106
Injection of drug into eye	81	$54,580	$95
Imaging of retina	222	$37,566	$33
Destruction of leaking blood vessels of retina using laser	27	$12,678	$295
Exam of retinal blood vessels using a special camera after injection of a dye	80	$10,073	$108
Compounded drug, not otherwise classified	39	$8,740	None
Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye	11	$2,754	$212
New patient complete exam of visual system	20	$2,599	$130
Established patient problem focused exam of visual system	21	$2,484	$73
Return visit (30+ min)	18	$2,204	$105
New patient visit (45+ min)	11	$1,308	$119

2022: 12 services

Sort by

Original Medicare services billed in 2022

Injection, ranibizumab, 0.1 mg	64	$411,418	None
Established patient complete exam of visual system	183	$109,551	$109
Injection of drug into eye	86	$63,093	$97
Imaging of retina	187	$36,745	$34
Destruction of leaking blood vessels of retina using laser	34	$15,957	$290
Exam of retinal blood vessels using a special camera after injection of a dye	112	$15,060	$98
Compounded drug, not otherwise classified	33	$5,972	None
Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye	22	$5,326	$213
New patient complete exam of visual system	22	$2,662	$121
Photography of the retina	66	$1,711	$22
Established patient problem focused exam of visual system	16	$1,449	$81
2d ultrasound scan of eye tissue and structures	12	$663	$35

2021: 13 services

Sort by

Original Medicare services billed in 2021

Injection, ranibizumab, 0.1 mg	47	$298,420	None
Established patient complete exam of visual system	193	$86,338	$112
Injection of drug into eye	71	$45,038	$101
Imaging of retina	173	$26,474	$35
Exam of retinal blood vessels using a special camera after injection of a dye	119	$13,907	$95
Destruction of leaking blood vessels of retina using laser	28	$13,277	$309
Compounded drug, not otherwise classified	34	$4,888	None
Photography of the retina	130	$4,678	$28
Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye	18	$3,940	$219
Established patient problem focused exam of visual system	19	$3,242	$83
New patient complete exam of visual system	18	$2,400	$133
Injection, bevacizumab, 10 mg	12	$846	None
2d ultrasound scan of eye tissue and structures	13	$837	$36

2020: 13 services

Sort by

Original Medicare services billed in 2020

Injection, ranibizumab, 0.1 mg	59	$344,058	None
Established patient complete exam of visual system	175	$73,586	$112
Injection of drug into eye	86	$38,419	$87
Imaging of retina	152	$24,066	$35
Destruction of leaking blood vessels of retina using laser	31	$16,106	$304
Exam of retinal blood vessels using a special camera after injection of a dye	121	$11,999	$84
Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye	25	$5,886	$226
Photography of the retina	127	$5,050	$31
Injection, bevacizumab, 10 mg	34	$4,863	None
Established patient problem focused exam of visual system	19	$2,614	$79
New patient complete exam of visual system	16	$2,203	$138
New patient visit (45+ min)	12	$1,444	$120
2d ultrasound scan of eye tissue and structures	19	$1,173	$40

2019: 14 services

Sort by

Original Medicare services billed in 2019

Injection, ranibizumab, 0.1 mg	73	$345,618	None
Established patient complete exam of visual system	188	$53,849	$111
Injection of drug into eye	86	$35,962	$88
Imaging of retina	144	$18,106	$34
Destruction of leaking blood vessels of retina using laser	36	$16,042	$303
Exam of retinal blood vessels using a special camera after injection of a dye	146	$14,502	$76
Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye	41	$11,268	$209
Photography of the retina	164	$9,956	$38
Established patient problem focused exam of visual system	66	$9,864	$75
Destruction of growth of retina using a laser	13	$7,036	$440
Photocoagulation treatment to prevent detachment of retina	11	$5,684	$474
Injection, bevacizumab, 10 mg	49	$4,988	None
2d ultrasound scan of eye tissue and structures	22	$1,916	$53
New patient visit (45+ min)	13	$1,869	$144

2018: 12 services

Sort by

Original Medicare services billed in 2018

Injection, ranibizumab, 0.1 mg	13	$35,409	None
Established patient complete exam of visual system	103	$20,827	$109
Injection of drug into eye	49	$13,785	$87
Established patient problem focused exam of visual system	60	$10,571	$76
Imaging of retina	101	$9,141	$34
Injection, bevacizumab, 10 mg	41	$7,356	None
Exam of retinal blood vessels using a special camera after injection of a dye	63	$6,353	$77
Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye	25	$6,310	$204
Destruction of leaking blood vessels of retina using laser	13	$5,753	$303
Photography of the retina	65	$3,935	$45
New patient visit (45+ min)	14	$1,791	$128
2d ultrasound scan of eye tissue and structures	11	$1,461	$66

2017: 6 services

Sort by

Original Medicare services billed in 2017

Established patient problem focused exam of visual system	29	$3,006	$75
Established patient complete exam of visual system	15	$2,019	$106
Injection of drug into eye	14	$1,868	$89
Imaging of retina	37	$1,746	$35
Injection, bevacizumab, 10 mg	14	$1,236	None
Exam of retinal blood vessels using a special camera after injection of a dye	12	$928	$71

2014: 4 services

Sort by

Original Medicare services billed in 2014

Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	104	$23,681	$83
Initial hospital care with moderate level of medical decision making at least 75 minutes	67	$11,191	$162
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	46	$5,361	$58
Hospital discharge day management, more than 30 minutes	47	$4,210	$86

2013: 5 services

Sort by

Original Medicare services billed in 2013

Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	369	$77,902	$81
Initial hospital care with moderate level of medical decision making at least 75 minutes	253	$42,076	$157
Hospital discharge day management, more than 30 minutes	176	$15,342	$84
Critical care, first 30-74 minutes	44	$11,122	$174
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	19	$1,907	$56

Medicaid work

$319,383 in 2024

Medicaid paid $319,383 for 6,601 billed services this clinician did in 2024, up to 224 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2024

Intravitreal injection of a pharmacologic agent (separate procedure)	855	$168,553
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina	2,659	$48,367
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST	1,826	$45,963
Injection, bevacizumab, 10 mg	676	$31,050
Return visit (30+ min)	325	$8,486
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI	134	$8,156
New patient visit (45+ min)	107	$4,907
TREATMENT X10SV RETINOPATHY	19	$3,901

Sort by

Medicaid work by year

2024	6,601	8	224	$319,383
2023	8,095	9	203	$514,311
2022	7,044	11	159	$514,002
2021	5,090	7	113	$334,394
2020	3,737	8	94	$202,418
2019	2,100	8	80	$80,199
2018	168	2	21	$499

See the largest Medicaid services in earlier years

2023

Sort by

Largest Medicaid services in 2023

Intravitreal injection of a pharmacologic agent (separate procedure)	1,231	$258,175
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina	2,996	$69,643
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST	2,097	$60,081
Injection, bevacizumab, 10 mg	890	$44,586
Ranibizumab injection	76	$28,354
TREATMENT X10SV RETINOPATHY	109	$23,760
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI	280	$16,068
Return visit (30+ min)	373	$11,682
New patient visit (45+ min)	43	$1,961

2022

Sort by

Largest Medicaid services in 2022

Intravitreal injection of a pharmacologic agent (separate procedure)	1,067	$240,190
Ranibizumab injection	188	$65,582
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina	2,054	$53,958
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST	1,788	$47,338
Injection, bevacizumab, 10 mg	807	$42,410
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI	401	$24,816
TREATMENT X10SV RETINOPATHY	87	$17,236
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT	356	$13,058
Return visit (30+ min)	268	$8,381
OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST	13	$529
OPH US DX B-SCAN	15	$503

2021

Sort by

Largest Medicaid services in 2021

Intravitreal injection of a pharmacologic agent (separate procedure)	807	$174,106
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST	1,493	$49,722
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina	1,370	$41,312
Injection, bevacizumab, 10 mg	628	$31,194
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI	313	$19,165
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT	464	$16,124
TREATMENT X10SV RETINOPATHY	15	$2,771

2020

Sort by

Largest Medicaid services in 2020

Intravitreal injection of a pharmacologic agent (separate procedure)	549	$97,985
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST	1,090	$25,920
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina	1,073	$25,088
Injection, bevacizumab, 10 mg	351	$17,562
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI	284	$12,177
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT	359	$9,948
Ranibizumab injection	13	$9,453
TREATMENT X10SV RETINOPATHY	18	$4,286

2019

Sort by

Largest Medicaid services in 2019

Intravitreal injection of a pharmacologic agent (separate procedure)	278	$31,441
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST	632	$11,131
Ranibizumab injection	33	$10,805
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina	688	$10,021
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI	170	$5,706
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT	198	$4,418
TREATMENT X10SV RETINOPATHY	34	$4,269
Injection, bevacizumab, 10 mg	67	$2,407

2018

Sort by

Largest Medicaid services in 2018

Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina	154	$499
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST	14	$0

Drugs they prescribed that Part D paid

$79,321

Pharmacies billed $79,321 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,281) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

712 generic and 569 brand-name prescriptions · $79,321 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Combigan	57	$10,735	$188
Lumigan	26	$8,454	$325
Brimonidine Tartrate-Timolol	120	$8,102	$68
Prednisolone Acetate	263	$7,155	$27
Brimonidine	91	$5,461	$60

See all 16 drugs

Sort by

Every Part D drug this clinician prescribed

Combigan	57	$10,735	$188
Lumigan	26	$8,454	$325
Brimonidine Tartrate-Timolol	120	$8,102	$68
Prednisolone Acetate	263	$7,155	$27
Brimonidine	91	$5,461	$60
Rocklatan	13	$4,437	$341
Rhopressa	14	$4,326	$309
Ofloxacin	185	$1,577	$9
Bimatoprost	12	$961	$80
Dorzolamide-Timolol	47	$879	$19
Latanoprost	165	$874	$5
Moxifloxacin	39	$806	$21
Ketorolac Tromethamine	44	$648	$15
Erythromycin	58	$577	$10
Timolol Maleate	41	$453	$11
Dorzolamide	23	$387	$17

Year by year

Sort by

Part D prescribing by year

2024	1,281	249	0% (0)	44%	$79,321
2023	984	206	0% (0)	48%	$75,326
2022	887	208	0% (0)	50%	$93,279
2021	781	199	0% (0)	46%	$71,331
2020	696	195	0% (0)	40%	$50,730
2019	454	146	0% (0)	38%	$33,503
2018	402	114	None	35%	$24,009
2017	114	44	0% (0)	32%	$6,611
2016	101	46	0% (0)	33%	$6,935
2015	90	48	None	27%	$3,840
2014	98	48	None	20%	$2,899
2013	231	112	6% (13)	None	$6,634

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 14 drugs

Sort by

Part D drugs prescribed in 2023

Combigan	46	$14,587	$317
Lumigan	24	$11,178	$466
Prednisolone Acetate	218	$8,393	$38
Alphagan P	20	$6,375	$319
Brimonidine	90	$4,614	$51
Brimonidine Tartrate-Timolol	25	$3,554	$142
Ofloxacin	183	$2,577	$14
Latanoprost	131	$1,797	$14
Bimatoprost	16	$1,467	$92
Ketorolac Tromethamine	50	$1,213	$24
Dorzolamide	23	$1,109	$48
Dorzolamide-Timolol	19	$728	$38
Erythromycin	49	$497	$10
Timolol Maleate	23	$236	$10

2022: 14 drugs

Sort by

Part D drugs prescribed in 2022

Lumigan	33	$19,294	$585
Alphagan P	50	$11,986	$240
Combigan	38	$8,859	$233
Prednisolone Acetate	166	$6,201	$37
Brimonidine	65	$4,291	$66
Brimonidine Tartrate-Timolol	19	$3,684	$194
Latanoprost	116	$2,224	$19
Ofloxacin	145	$1,802	$12
Dorzolamide	31	$1,271	$41
Ketorolac Tromethamine	60	$1,254	$21
Acetazolamide Er	13	$918	$71
Dorzolamide-Timolol	21	$769	$37
Erythromycin	22	$336	$15
Timolol Maleate	21	$245	$12

2021: 15 drugs

Sort by

Part D drugs prescribed in 2021

Lumigan	31	$13,909	$449
Alphagan P	26	$8,938	$344
Brimonidine	80	$5,976	$75
Prednisolone Acetate	129	$5,619	$44
Brinzolamide	12	$4,165	$347
Combigan	17	$3,349	$197
Latanoprost	93	$2,019	$22
Timolol Maleate	55	$1,677	$30
Dorzolamide	34	$1,632	$48
Ketorolac Tromethamine	66	$1,490	$23
Ofloxacin	76	$1,125	$15
Moxifloxacin	24	$1,008	$42
Erythromycin	38	$590	$16
Dorzolamide-Timolol	14	$515	$37
Neomycin-Polymyxin-Dexameth	24	$455	$19

2020: 13 drugs

Sort by

Part D drugs prescribed in 2020

Combigan	27	$7,580	$281
Brimonidine	75	$6,317	$84
Alphagan P	17	$6,147	$362
Prednisolone Acetate	122	$4,697	$39
Lumigan	17	$4,531	$267
Latanoprost	132	$2,397	$18
Dorzolamide	36	$1,856	$52
Ketorolac Tromethamine	69	$1,729	$25
Timolol Maleate	37	$726	$20
Moxifloxacin	12	$701	$58
Ofloxacin	62	$697	$11
Dorzolamide-Timolol	15	$592	$39
Erythromycin	17	$233	$14

2019: 11 drugs

Sort by

Part D drugs prescribed in 2019

Alphagan P	23	$8,567	$372
Brimonidine	63	$4,513	$72
Combigan	14	$3,641	$260
Prednisolone Acetate	52	$2,231	$43
Latanoprost	107	$1,236	$12
Dorzolamide	30	$1,037	$35
Dorzolamide-Timolol	12	$834	$69
Ketorolac Tromethamine	33	$788	$24
Timolol Maleate	22	$785	$36
Ofloxacin	28	$408	$15
Erythromycin	14	$204	$15

2018: 8 drugs

Sort by

Part D drugs prescribed in 2018

Prednisolone Acetate	66	$2,831	$43
Brimonidine	36	$2,517	$70
Cosopt Pf	13	$2,015	$155
Latanoprost	82	$1,785	$22
Ketorolac Tromethamine	50	$1,234	$25
Dorzolamide-Timolol	19	$597	$31
Ofloxacin	29	$489	$17
Timolol Maleate	21	$144	$7

2017: 3 drugs

Sort by

Part D drugs prescribed in 2017

Prednisolone Acetate	20	$1,019	$51
Ketorolac Tromethamine	12	$381	$32
Ofloxacin	13	$323	$25

2016: 2 drugs

Sort by

Part D drugs prescribed in 2016

Dorzolamide	12	$278	$23
Dorzolamide-Timolol	11	$218	$20

2015: 1 drug

Sort by

Part D drugs prescribed in 2015

Erythromycin	19	$263	$14

2013: 5 drugs

Sort by

Part D drugs prescribed in 2013

Levofloxacin	33	$301	$9
Cefuroxime	13	$119	$9
Amlodipine Besylate	17	$108	$6
Lisinopril	12	$86	$7
Prednisone	15	$60	$4

Money from drug and device companies

$288 in 2025

Sort by

Industry payments by year

2025	2	3	None	$288
2024	2	3	None	$79
2023	3	3	None	$402
2022	3	12	None	$492
2021	3	7	None	$136
2020	2	4	None	$68
2019	4	7	None	$234

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Apellis Pharmaceuticals	Syfovre	$265	2 payments Meals · 2025-07-29 · $144 Meals for Syfovre · 2025-05-28 · $121
Genentech USA	Susvimo	$24	1 payment Meals for Susvimo · 2025-01-15 · $24

See all 3 published payments

Sort by

Every published payment

Apellis Pharmaceuticals	Meals · 2025-07-29	None	$144
Apellis Pharmaceuticals	Meals · 2025-05-28	Syfovre	$121
Genentech USA	Meals · 2025-01-15	Susvimo	$24

See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $79

Sort by

Payments by company in 2024

Alcon Vision	Hydrus Microstent	$44	2 payments Meals for Hydrus Microstent · 2024-05-15 · $25 Meals for Hydrus Microstent · 2024-03-20 · $19
Carl Zeiss Meditec USA	Lumera 700	$35	1 payment Meals for Lumera 700 · 2024-06-11 · $35

2023: $402

Sort by

Payments by company in 2023

Dutch Ophthalmic USA	Eva, Combined Machine	$172	1 payment Meals for Eva, Combined Machine · 2023-11-06 · $172
Apellis Pharmaceuticals	Syfovre	$120	1 payment Meals for Syfovre · 2023-04-12 · $120
Genentech	Vabysmo	$111	1 payment Meals for Vabysmo · 2023-09-13 · $111

2022: $492

Sort by

Payments by company in 2022

Genentech USA	Susvimo	$432	9 payments Meals · 2022-07-22 · $34 Meals for Susvimo · 2022-06-13 · $23 Meals for Susvimo · 2022-05-04 · $13 Meals for Susvimo · 2022-05-02 · $26 Meals for Vabysmo · 2022-04-20 · $134 Meals for Susvimo · 2022-03-22 · $134 Meals for Vabysmo · 2022-03-10 · $25 Meals for Lucentis · 2022-01-28 · $25 Meals for Lucentis · 2022-01-20 · $18
Alimera Sciences	Iluvien	$43	2 payments Meals for Iluvien · 2022-06-21 · $24 Meals for Iluvien · 2022-06-06 · $19
Exeltis USA	Purified Cortrophin Gel	$17	1 payment Meals for Purified Cortrophin Gel · 2022-08-04 · $17

2021: $136

Sort by

Payments by company in 2021

Alimera Sciences	Iluvien	$69	4 payments Meals for Iluvien · 2021-11-15 · $16 Meals for Iluvien · 2021-08-27 · $16 Meals for Iluvien · 2021-04-09 · $19 Meals for Iluvien · 2021-02-01 · $18
Horizon Therapeutics plc	Tepezza	$42	2 payments Meals for Tepezza · 2021-12-14 · $19 Meals for Tepezza · 2021-04-13 · $23
Genentech USA	Lucentis	$25	1 payment Meals for Lucentis · 2021-12-13 · $25

2020: $68

Sort by

Payments by company in 2020

Alimera Sciences	Iluvien	$45	3 payments Meals for Iluvien · 2020-04-21 · $12 Meals for Iluvien · 2020-02-05 · $15 Meals for Iluvien · 2020-01-21 · $17
Horizon Therapeutics plc	Tepezza	$24	1 payment Meals for Tepezza · 2020-02-27 · $24

2019: $234

Sort by

Payments by company in 2019

Alcon Vision	None	$111	1 payment Meals · 2019-10-12 · $111
Alimera Sciences	Iluvien	$76	4 payments Meals for Iluvien · 2019-09-03 · $19 Meals for Iluvien · 2019-06-21 · $20 Meals for Iluvien · 2019-04-05 · $18 Meals for Iluvien · 2019-02-22 · $19
Bausch & Lomb a division of Bausch Health US	Stellaris PC	$24	1 payment Meals for Stellaris PC · 2019-02-06 · $24
Genentech USA	Lucentis	$23	1 payment Meals for Lucentis · 2019-06-04 · $23

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 75.0 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1003072786
Licence: CA A108797, MA 242108California A108797: Current · expires 2027-04-30
Group: Retina Institute of California Medical Group, A California Medical Par
Gender: Male

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207WX0107X (207WX0107X); Internal medicine (207R00000X); Federal specialty code 207W00000X (207W00000X)
Mailing address: 288 N Santa Anita Ave Ste 402, Arcadia, CA, 91006
NPI first listed: 2008-08-01
NPI last updated: 2026-05-22
NPI record certified: 2026-05-22

This is when the NPI record was last certified, not a medical board exam.